Late-stage process development (PD): |
Cell bank used |
MCB or WCB |
RCB |
Medium and process conditions |
Optimization for 3-6 months |
Platform fit within 1-2 months |
Scale-up runs |
MCB or WCB |
RCB |
Late-stage, pivotal, and PPQ GMP campaigns: |
PD, tech transfer, and MBR preparation |
Staged one by one |
Simultaneously |
Cell bank |
WCB |
MCB |
Process characterization (PC): |
FMEA |
After completion of PD and pivotal campaign with all data generated |
In parallel with PD and pivotal campaign, when partial PD and pivotal campaign data generated, while leveraging platform knowledge and other project experiences |
Media and seed culture used in PC |
Generated in lab only |
Generated in either lab or GMP facility |
SDM development |
Multiple screening runs for all parameters |
One run for scale-dependent parameters only |
SDM qualification before PC studies |
With sufficient SDM lab and large-scale data |
Preliminary qualification with limited PD and large-scale data |
SDM qualification before PPQ campaign |
NA |
Retrospectively qualify SDM using sufficient PC lab and pivotal campaign data |
PC studies before PPQ |
Raw materials and medium preparation, inoculum expansion, seed and production bioreactors, LIVCA, and worst-case linkage studies |
Focus on the most important PC studies: production bioreactor DOE and LIVCA |
PC studies after PPQ |
NA |
Worst-case linkage PC study |
PC report writing and approval |
To support IPC reports Before PPQ initiation |
After PPQ initiation |
PC memo writing and approval |
NA |
To support IPC reports |
In-process control (IPC): |
PC data format to support IPC |
Final PC reports |
PC memos as appendices |
Raw Materials, Inoculum, and Seed Bioreactors IPC reports |
Written before PPQ using PC data |
Written before PPQ using PD and pivotal campaign data as memos, platform knowledge, and other project experiences |
Production Bioreactor IPC report |
Written before PPQ using PC data |
Written after PPQ vial thaw, but before first production bioreactor run using PC data |